RSLS - RESHAPE LIFESCIENCES INC by ReShape Lifesciences Inc. Summary, Stock Quote and News | Benzinga

Market Overview

0.0610 -0.199 (-76.51%)

Data as of Dec 05, 2019

Prev. Close 0.2597
Price Open
Volume 0
Day's Range -
52 Wk Range -
50 Day Moving Avg.
PE Ratio 0
Shares Outstanding
Market Cap

Trade RSLS stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

ReShape Lifesciences Announces 1-For-120 Reverse Stock Split Effective Nov. 12 Benzinga NewsdeskMon, 11 Nov 2019 12:53:30 -0500
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering Shanthi RexalineWed, 14 Aug 2019 06:50:27 -0500
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout Shanthi RexalineWed, 07 Aug 2019 06:34:05 -0500
Reshape Lifesciences Q1 EPS $(0.54) Down From $(0.36) YoY, Sales $3.074M Up From $139K YoY Benzinga NewsdeskMon, 20 May 2019 15:23:11 -0500
ReShape Lifesciences FY18 Sales $2.8M Up From $2.3M YoY Benzinga NewsdeskMon, 01 Apr 2019 15:09:42 -0500
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs Shanthi RexalineSat, 30 Mar 2019 08:32:40 -0500
48 Biggest Movers From Friday Lisa LevinMon, 31 Dec 2018 05:18:32 -0500
Mid-Afternoon Market Update: Dow Rises 150 Points; Obalon Therapeutics Shares Plunge Lisa LevinFri, 28 Dec 2018 14:21:21 -0500
26 Stocks Moving In Friday's Mid-Day Session Lisa LevinFri, 28 Dec 2018 12:43:17 -0500
Mid-Day Market Update: Crude Oil Up Over 1%; Quantum Shares Spike Higher Lisa LevinFri, 28 Dec 2018 12:18:02 -0500
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences Announces Third Quarter 2019 Financial Results ACCESSWIRENov 14, 2019
ReShape Lifesciences Announces 1-for-120 Reverse Stock Split ACCESSWIRENov 11, 2019
ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019 ACCESSWIRENov 07, 2019
ReShape Lifesciences Announces Strategic Marketing Partnership for LAP-BAND(R) ACCESSWIRENov 05, 2019
ReShape Lifesciences Appoints Thomas Stankovich as Chief Financial Officer ACCESSWIREOct 30, 2019
ReShape Lifesciences Announces Attendance and Presentation at Obesity Week 2019 ACCESSWIREOct 17, 2019
ReShape Lifesciences Enters into Early Warrant Exercise Transaction and Receives an Additional $7.65 Million in Proceeds ACCESSWIRESep 23, 2019
ReShape Lifesciences(TM) to Participate in the H. C. Wainwright Global Investment Conference ACCESSWIRESep 03, 2019
ReShape Lifesciences(TM) to Highlight Products at IFSO 24th World Congress ACCESSWIREAug 22, 2019
ReShape Lifesciences Announces Second Quarter 2019 Financial Results ACCESSWIREAug 14, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

ReShape Lifesciences' (RSLS) CEO Bart Bandy on Q3 2019 Results - Earnings Call Transcript Seeking AlphaNov 14, 2019
ReShape Lifesciences reports Q3 results Seeking AlphaNov 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q2 2019 Results - Earnings Call Transcript Seeking AlphaAug 14, 2019
ReShape Lifesciences reports Q2 results Seeking AlphaAug 14, 2019
ReShape Lifesciences Inc. (RSLS) CEO Bart Bandy on Q1 2019 Results - Earnings Call Transcript Seeking AlphaMay 20, 2019
ReShape Lifesciences reports Q1 results Seeking AlphaMay 20, 2019
ReShape Lifesciences Inc.'s (RSLS) CEO Dan Gladney on Q4 2018 Results - Earnings Call Transcript Seeking AlphaApr 01, 2019
ReShape Lifesciences reports Q4 results Seeking AlphaApr 01, 2019
ReShape Lifesciences announces $2M convertible note financing Seeking AlphaMar 29, 2019
New CEO at ReShape Lifesciences Seeking AlphaMar 26, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Powered by StockSnips

63.16% Positive

Earnings View Earnings

Q3 2019	EST	Actual	Surprise
EPS:	Expected 2019-11-14
Rev:	Expected 2019-11-14

Q4 2019	EST	Actual	Surprise
EPS:	Expected 2020-03-30
Rev:	Expected 2020-03-30

Brokerage Center

Compare All Online Brokerages

Book A Demo

Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo